XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in XBiotech Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −4 vs. Q3 2022
- Shares held
- 2.76M
- −302.3K (−9.9%) vs. Q3 2022
- Total value
- $9.68M
- −$1.40M (−12.6%) vs. Q3 2022
- New holders
- 1
- 7 more added
- Sold out
- 5
- 19 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $4.56M |
| Q1 2026 | 37 | $4.68M |
| Q4 2025 | 41 | $5.48M |
| Q3 2025 | 48 | $7.81M |
| Q2 2025 | 53 | $10.1M |
| Q1 2025 | 55 | $14.5M |
| Q4 2024 | 53 | $18.6M |
| Q3 2024 | 50 | $37.5M |
| Q2 2024 | 46 | $23.2M |
| Q1 2024 | 46 | $32.5M |
| Q4 2023 | 39 | $13.8M |
| Q3 2023 | 38 | $14.0M |
| Q2 2023 | 39 | $20.7M |
| Q1 2023 | 39 | $8.61M |
| Q4 2022 | 41 | $9.68M |
| Q3 2022 | 45 | $11.1M |
| Q2 2022 | 56 | $18.9M |
| Q1 2022 | 64 | $34.9M |
| Q4 2021 | 61 | $46.8M |
| Q3 2021 | 66 | $56.7M |
| Q2 2021 | 56 | $66.8M |
| Q1 2021 | 65 | $74.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding XBiotech Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 38 | $0 | 0.00% | −11,098−99.7% | Reduced |
| Wells Fargo & Company | 120 | $421 | 0.00% | +3+2.6% | Added |
| Tower Research Capital LLC (TRC) | 171 | $1.00K | 0.00% | −2,400−93.3% | Reduced |
| IFP Advisors, Inc | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 350 | $1.00K | 0.00% | 00.0% | Unchanged |
| Financial Connections Group, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 400 | $1.40K | 0.00% | −1,626−80.3% | Reduced |
| McIlrath & Eck, LLC | 753 | $2.64K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,897 | $20.7K | 0.00% | +614+11.6% | Added |
| LGT Fund Management Co Ltd. | 10,000 | $35.1K | 0.02% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 10,477 | $36.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 11,725 | $41.2K | 0.00% | +11,725 | New |
| Synovus Financial Corp | 11,796 | $41.4K | 0.00% | 00.0% | Unchanged |
| Trexquant Investment LP | 12,985 | $45.6K | 0.00% | −8,990−40.9% | Reduced |
| HRT Financial LP | 13,279 | $46.0K | 0.00% | −27,708−67.6% | Reduced |
| Thomasville National Bank | 13,350 | $47.0K | 0.01% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 15,052 | $52.8K | 0.00% | −33,097−68.7% | Reduced |
| Price T Rowe Associates Inc | 17,600 | $62.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18,734 | $65.8K | 0.00% | +11,391+155.1% | Added |
| FMR LLC | 20,280 | $71.2K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 20,863 | $73.2K | 0.00% | −537−2.5% | Reduced |
| State of Wisconsin Investment Board | 25,000 | $87.8K | 0.00% | −4,706−15.8% | Reduced |
| Acadian Asset Management LLC | 37,576 | $130.0K | 0.00% | −7,874−17.3% | Reduced |
| Northern Trust Corp | 44,687 | $156.9K | 0.00% | −141−0.3% | Reduced |
| Man Group plc | 49,013 | $172.0K | 0.00% | +31,713+183.3% | Added |
| Millennium Management LLC | 52,244 | $183.0K | 0.00% | −85,743−62.1% | Reduced |
| Bank of New York Mellon Corp | 55,693 | $195.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 57,295 | $201.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 59,600 | $209.2K | 0.00% | −9,700−14.0% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 65,026 | $228.2K | 0.00% | −2,949−4.3% | Reduced |
| Two Sigma Investments, LP | 66,036 | $231.8K | 0.00% | −11,061−14.3% | Reduced |
| Dimensional Fund Advisors LP | 82,398 | $290.0K | 0.00% | −3,875−4.5% | Reduced |
| Morgan Stanley | 98,357 | $345.2K | 0.00% | −14,801−13.1% | Reduced |
| Renaissance Technologies LLC | 101,468 | $356.0K | 0.00% | −54,000−34.7% | Reduced |
| Bridgeway Capital Management, LLC | 123,400 | $433.1K | 0.01% | −9,600−7.2% | Reduced |
| Oasis Management Co Ltd. | 137,174 | $481.5K | 0.10% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 155,083 | $544.0K | 0.00% | +3,342+2.2% | Added |
| Credit Suisse AG | 245,270 | $860.9K | 0.00% | −18,438−7.0% | Reduced |
| BlackRock Inc. | 261,201 | $916.8K | 0.00% | +2,267+0.9% | Added |
| Vanguard Group Inc | 854,469 | $3.00M | 0.00% | +3520.0% | Added |
| RBF Capital, LLC | 0 | $0 | 0.00% | −23,172−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,591−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,439−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −8,982−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −209−100.0% | Sold out |